Vector-Borne Disease Surveillance AI Market Report 2026

The vector-borne disease surveillance artificial intelligence (AI) market size has grown rapidly in recent years. It will grow from $1.6 billion in 2025 to $1.92 billion in 2026 at a compound annual growth rate (CAGR) of 19.9%. The growth in the historic period can be attributed to increase in vector borne disease outbreaks, expansion of public health surveillance programs, growth in geospatial health data, global health monitoring initiatives, adoption of digital disease reporting.

The vector-borne disease surveillance artificial intelligence (AI) market size is expected to see exponential growth in the next few years. It will grow to $4.01 billion in 2030 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to AI based epidemic forecasting demand, climate change driven vector spread, smart sensor surveillance networks, cross border health data platforms, predictive public health planning. Major trends in the forecast period include AI driven outbreak prediction models, climate linked vector risk mapping, automated species identification systems, real time epidemiological dashboards, integrated multi source surveillance platforms.

The rising incidence of vector-borne diseases is expected to support the expansion of the vector-borne disease surveillance artificial intelligence (AI) market in the coming years. Vector-borne diseases are illnesses caused by pathogens transmitted through vectors such as mosquitoes, ticks, and fleas, and they represent a growing global public health challenge. The increasing occurrence of these diseases is driven by climate change, urbanization, population movement, and expanding vector habitats, which have resulted in wider geographic spread and more frequent outbreaks. AI-powered vector-borne disease surveillance helps address these challenges by enabling real-time data integration, early outbreak identification, predictive analytics, and improved allocation of public health resources. For example, according to the Pan American Health Organization (PAHO), as reported by the UK Health Security Agency in June 2024, the Region of the Americas recorded 9,386,082 dengue cases, including 4,630,669 confirmed cases and 4,529 deaths between January and June 2024, representing a 103.29% increase compared to the same period in 2023. Therefore, the rising incidence of vector-borne diseases is advancing the growth of the vector-borne disease surveillance AI market.

Leading companies operating in the vector-borne disease surveillance AI market are focusing on technological advancements in real-time vector prediction, such as AI-powered smart surveillance systems, to gain competitive advantage through improved outbreak forecasting, targeted intervention capabilities, and enhanced public health decision-making. These systems integrate artificial intelligence with Internet-of-Things sensors and analytics to monitor mosquito populations, detect species and environmental conditions, and trigger alerts for targeted interventions, enabling more precise and timely public health responses compared to traditional methods. For instance, in July 2025, the Andhra Pradesh Municipal Administration and Urban Development Department, a public sector urban development entity in India, introduced the Smart Mosquito Surveillance System (SMoSS). The Smart Mosquito Surveillance System (SMoSS) provides an AI-driven, real-time monitoring platform to track mosquito populations in high-risk urban areas. It integrates smart sensors, traps, drones, and IoT infrastructure to collect continuous field data and generate heat maps identifying mosquito breeding and infestation hotspots.

In June 2025, bioMérieux, a France-based provider of in vitro diagnostic technologies, acquired the assets of Day Zero Diagnostics for an undisclosed amount. This acquisition aims to enhance bioMérieux’s next-generation sequencing and machine learning capabilities, enabling faster identification of infectious pathogens and antibiotic resistance profiles for real-time disease surveillance. Day Zero Diagnostics is a US-based company specializing in machine learning-powered genome sequencing solutions for rapid pathogen detection.

Major companies operating in the vector-borne disease surveillance artificial intelligence (AI) market are Amazon Web Services Inc., Microsoft Corporation, International Business Machines Corporation, Siemens Healthineers AG, Plexus Health Surveillance, SAS Institute Inc., Palantir Technologies Inc., Informatica LLC, Vector Surveillance System, Environmental Systems Research Institute Inc., Cloudera Inc., HealthMap, GIDEON Informatics, Metabiota Inc., EcoHealth Alliance Inc., BlueDot Inc., BioSense Technologies, Artificial Intelligence in Medical Epidemiology, Vector Technology & Management Consulting Group, Aira Matrix.

Tariffs are affecting the vector borne disease surveillance AI market mainly through increased costs of imported sensors, field detection devices, and surveillance hardware. Higher duties on monitoring equipment and networking devices are raising deployment costs for public health agencies and research programs. Regions dependent on imported sensing and diagnostic hardware are seeing slower rollout of integrated surveillance systems. Hardware intensive field monitoring segments are more exposed than pure software analytics platforms. Cloud based AI tools are less directly impacted by tariff changes. At the same time, tariffs are encouraging local manufacturing of sensing and monitoring equipment. This supports regional health technology suppliers and system integrators.

The vector-borne disease surveillance artificial intelligence (AI) market research report is one of a series of new reports that provides vector-borne disease surveillance artificial intelligence (AI) market statistics, including vector-borne disease surveillance artificial intelligence (AI) industry global market size, regional shares, competitors with a vector-borne disease surveillance artificial intelligence (AI) market share, detailed vector-borne disease surveillance artificial intelligence (AI) market segments, market trends and opportunities, and any further data you may need to thrive in the vector-borne disease surveillance artificial intelligence (AI) industry. This vector-borne disease surveillance artificial intelligence (AI) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vector borne disease surveillance artificial intelligence (AI) involves the application of AI technologies to monitor, predict, and control diseases transmitted by vectors such as mosquitoes, ticks, and other insects. It analyzes environmental, climate, and health data to identify trends and forecast outbreaks with greater precision. This system supports faster responses and more effective public health interventions through real-time analysis of complex datasets.

The primary components of vector-borne disease surveillance artificial intelligence (AI) include software, hardware, and services. Software consists of AI-driven platforms that gather, process, and forecast the transmission patterns of vector-borne diseases using real-time data inputs. These platforms can be implemented through cloud-based environments or on-premises deployments. They are applied in malaria surveillance, dengue monitoring, Zika virus tracking, Lyme disease surveillance, and other applications, and are used by end users such as government agencies, healthcare providers, research institutes, and other end users.

The vector borne disease surveillance artificial intelligence (AI) market consists of revenues earned by entities by providing services such as real-time vector monitoring, outbreak prediction, data analysis and modeling, risk assessment, reporting and visualization, early warning alerts, decision support, public health intervention planning, predictive analytics, and surveillance system integration. The vector borne disease surveillance artificial intelligence (AI) market also includes sales of AI-powered species identification tools, smart surveillance & monitoring platforms, risk forecasting systems, community reporting apps, and pathogen detection platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.